Futakuchi M, Hirose M, Ogiso T, Kato K, Sano M, Ogawa K, Shirai T
First Department of Pathology, Nagoya City University Medical School, Nagoya.
Jpn J Cancer Res. 1999 Nov;90(11):1196-202. doi: 10.1111/j.1349-7006.1999.tb00695.x.
We previously found by chance that N-nitrosomorpholine (NMOR) given after a multi-carcinogenic treatment induces liver carcinomas with 56% lung metastasis, and it was confirmed that hepatocellular carcinoma (HCC) with 100% lung metastasis was produced by 24-week treatment with NMOR and additional treatment with diethylnitrosamine (DEN). In the present study, we modified the duration of NMOR to establish an animal model with a simple experimental protocol and an appropriate experimental duration which would facilitate further study of the mechanisms of metastasis and antimetastatic agents. The results revealed DEN exposure followed by a 16-week treatment with NMOR to be a most efficient method for the induction of HCC metastasizing to the lung. Loss of cadherin, demonstrated immunohistochemically, occurred in an early stage of carcinogenesis, and this was reflected in malignant conversion of primary lesions. This model, with its essential similarities to malignant tumor behavior in man, should find application not only for elucidation of the mechanisms underlying metastasis, but also in the development of anti-metastatic agents.
我们之前偶然发现,在进行多致癌处理后给予N-亚硝基吗啉(NMOR)可诱导产生有56%肺转移的肝癌,并且证实,通过用NMOR进行24周处理并额外给予二乙基亚硝胺(DEN)可产生有100%肺转移的肝细胞癌(HCC)。在本研究中,我们改变了NMOR的处理时长,以建立一种具有简单实验方案和合适实验时长的动物模型,这将有助于进一步研究转移机制和抗转移药物。结果显示,先给予DEN,随后用NMOR进行16周处理,是诱导HCC转移至肺的最有效方法。免疫组化显示,钙黏蛋白的缺失发生在致癌作用的早期阶段,这在原发性病变的恶性转化中得以体现。该模型与人类恶性肿瘤行为基本相似,不仅应可用于阐明转移的潜在机制,还可用于抗转移药物的研发。